Last Updated: November 8, 2026

Details for New Drug Application (NDA): 217075

« Back to Dashboard

NDA 217075 describes TAZAROTENE, which is a drug marketed by Cosette Pharms Nc, Fougera Pharms Inc, Padagis Israel, Solaris Pharma Corp, and Sun Pharma Canada, and is included in ten NDAs. It is available from seven suppliers. Additional details are available on the TAZAROTENE profile page.

The generic ingredient in TAZAROTENE is tazarotene. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the tazarotene profile page.

Summary for 217075

Tradename:	TAZAROTENE
Applicant:	Padagis Israel
Ingredient:	tazarotene
Patents:	0

Pharmacology for NDA: 217075

Suppliers and Packaging for NDA: 217075

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TAZAROTENE	tazarotene	CREAM;TOPICAL	217075	ANDA	Padagis Israel Pharmaceuticals Ltd	45802-706	45802-706-94	1 TUBE in 1 CARTON (45802-706-94) / 30 g in 1 TUBE
TAZAROTENE	tazarotene	CREAM;TOPICAL	217075	ANDA	Padagis Israel Pharmaceuticals Ltd	45802-706	45802-706-96	1 TUBE in 1 CARTON (45802-706-96) / 60 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CREAM;TOPICAL			Strength	0.05%
Approval Date:	Jul 15, 2024	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.